TMDX CLASS ACTION ALERT: Lose Money when TransMedics Group, Inc. Plummeted 30%? Contact BFA Law about the Class Action Lawsuit
NEW YORK, March 10, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against TransMedics Group, Inc. (NASDAQ: TMDX) and certain of the Company's senior executives for potential violations of the federal securities laws.
If you invested in TransMedics, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/transmedics-group-inc.
Investors have until April 15, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors who purchased TransMedics securities. The case is pending in the U.S. District Court for the District of Massachusetts and is captioned Jewik v. TransMedics Group, Inc. et al, No. 25-cv-10385.
Why was TransMedics Sued for Fraud?
TransMedics is a commercial-stage medical technology company. The Company's 'Organ Care System' ('OCS') is a medical device that keeps donor organs viable before transplant by replicating many aspects of the organ's natural living and functioning environment outside of the human body.
The complaint alleges that TransMedics misrepresented that its business was driven by kickbacks, fraudulent overbilling, and coercive tactics. The complaint further alleges that the company misrepresented that it engaged in unsafe practices involving OCS, hid safety issues, and generally lacked safety oversight.
The Stock Declines as the Truth is Revealed
On February 21, 2024, U.S. Representative and member of the House Committee on Oversight and Accountability Paul Gosar issued a letter accusing the Company of misconduct including overcharging for OCS and misappropriating corporate resources. This news allegedly caused the price of TransMedics stock to decline approximately 4% over two trading days, from $86.99 per share on February 21, 2024 to $83.14 per share on February 23, 2024.
On December 2, 2024, TransMedics announced the resignation of its CFO from that role and narrowed its financial outlook for 2024. Then, on January 10, 2025, Scorpion Capital issued a research report explaining that TransMedics's growth was fueled by an anti-competitive scheme that included kickbacks to medical providers to use the company's products and that TransMedics further boosted growth by operating an organ trafficking scheme, engaged in widespread billing fraud, and promoted off-label use. The publication of the Scorpion Capital report caused the price of TransMedics stock to decline an additional 5%, from $72.55 per share on January 8, 2025 to $68.81 per share on January 10, 2025.
Click here for more information: .
What Can You Do?
If you invested in TransMedics you may have legal options and are encouraged to submit your information to the firm.
All representation is on a contingency fee basis, there is no cost to you. Shareholders are not responsible for any court costs or expenses of litigation. The firm will seek court approval for any potential fees and expenses.
Submit your information by visiting:
Or contact:
212-789-3619
Why Bleichmar Fonti & Auld LLP?
Bleichmar Fonti & Auld LLP is a leading international law firm representing plaintiffs in securities class actions and shareholder litigation. It was named among the Top 5 plaintiff law firms by ISS SCAS in 2023 and its attorneys have been named Titans of the Plaintiffs' Bar by Law360 and SuperLawyers by Thompson Reuters. Among its recent notable successes, BFA recovered over $900 million in value from Tesla, Inc.'s Board of Directors, as well as $420 million from Teva Pharmaceutical Ind. Ltd.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
7 minutes ago
- Yahoo
5 Cybersecurity Stocks You Can Buy and Hold for the Next Decade
Breaches have become too costly for companies not to invest in top-tier protection. Cybersecurity comes in several flavors, offering a range of choices for investors. The five stocks below offer broad industry exposure -- and should thrive over time. 10 stocks we like better than Palo Alto Networks › Security has become mission-critical to companies in an increasingly digital and technology-driven world. The consequences of failure are costly. An annual report by International Business Machines estimates that the typical breach can cost companies $4.9 million in damages. Therefore, it should come as no surprise that cybersecurity is a hot topic in the stock market. Research from Roots Analysis estimates that the global cybersecurity market will grow from $215 billion last year to $697 billion by 2035, representing an 11.3% annualized growth rate over the next decade. But don't look to the antivirus programs your parents used on their computers in the late 1990s. Today, a new crop of next-generation security companies is taking over the field. Here are five cybersecurity stocks to consider buying and holding for the next decade. A highly connected world creates security vulnerabilities. That's where Palo Alto Networks (NASDAQ: PANW) comes in. The company specializes in firewall technology, which acts like a security guard on a network, monitoring what is trying to get in, and stopping suspicious actors. The company has expanded into cloud security and integrated artificial intelligence (AI), a common theme on this list, to improve its protection. It is one of the largest dedicated cybersecurity companies and is driving growth by transitioning its business model from selling specific solutions tailored to individual customer needs to a platform strategy. Analysts estimate that Palo Alto Networks will continue to grow its earnings by an average of 20% annually over the long term, as spending across the broader security market increases. It's hard to discuss cutting-edge security without including CrowdStrike Holdings (NASDAQ: CRWD). The company has garnered recognition for its endpoint security, which protects connected devices (endpoints) in a network, such as laptops or smart devices. It has expanded to become a comprehensive security platform with enhanced capabilities, sold to customers as product modules. Cross-selling has driven staggering growth for CrowdStrike. Today, nearly a quarter of its customers use at least eight product modules. And with just $4.4 billion in annual recurring revenue, there is still ample room for growth. The company's success has fetched a lofty price-to-sales ratio (P/S) of 28, but it could be worth nibbling on and adding more aggressively on dips. CrowdStrike is on its way to becoming a substantial business. The internet runs on massive content delivery networks (CDN), and Cloudflare (NYSE: NET) is one of the largest. Beyond powering the internet, it helps secure it by mitigating distributed denial-of-service (DDoS) threats, a type of cyberattack where malicious traffic floods a site, slowing it or crashing it altogether. The company has over 250,000 paying customers, and its network is a great distribution tool for products and services. Its global CDN coverage also makes it a player in edge computing, where companies bring computing resources out of centralized cloud centers to localized locations to improve performance and speed. Think upcoming opportunities like autonomous vehicles and robotics, where secure, fast connections will be crucial for the technology to work at scale. Security technology often flags potential threats that a human analyst then reviews and assesses. SentinelOne (NYSE: S) uses AI to detect and deter cyberthreats autonomously. As a direct competitor to CrowdStrike, it also specializes in endpoint security and has received praise for its high-level technology capabilities. SentinelOne is smaller than its archrival and isn't yet profitable. However, it benefits from the same big-picture growth trends as the others on this list, and its P/S of 6.7 makes it arguably the bargain among this group. Sometimes, you don't need to be the biggest to be successful. The stock could have tremendous long-term upside from here. Cybersecurity isn't among the things investors associate with Microsoft (NASDAQ: MSFT), but make no mistake, the technology giant is a colossal presence in the industry. It builds security products and services into its Windows operating software, protecting millions of Windows computers and devices worldwide. Microsoft is involved with various technology end markets, so this is far more than a cybersecurity investment. The company's exposure to AI, cloud computing, and enterprise software -- as well as Windows and Microsoft 365 productivity software -- makes it a well-rounded bet on the broader technology sector. That's worth holding as an anchor for a growth-focused portfolio. Before you buy stock in Palo Alto Networks, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Palo Alto Networks wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $660,341!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $874,192!* Now, it's worth noting Stock Advisor's total average return is 999% — a market-crushing outperformance compared to 173% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 Justin Pope has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Cloudflare, CrowdStrike, International Business Machines, and Microsoft. The Motley Fool recommends Palo Alto Networks and recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy. 5 Cybersecurity Stocks You Can Buy and Hold for the Next Decade was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
11 minutes ago
- Yahoo
Insiders Pull the Trigger on These 2 Market-Beating Stocks
Investors searching for quality stock opportunities often look for reliable signals, and few are as telling as insider activity. Corporate insiders, such as top executives and directors, have an intimate understanding of their company's performance and prospects. When these insiders buy or sell shares, it can offer a powerful glimpse into their confidence – or concern – about what lies ahead. Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter To ensure transparency and fairness, federal regulators require insiders to publicly disclose their trades. These filings give everyday investors a unique chance to track where the people closest to the business are putting their money. And when insiders make substantial purchases it's typically because they have strong conviction that the stock is poised to rise. With this in mind, we turned to TipRanks' Insiders' Hot Stocks tool to identify promising names that insiders are actively buying. What we found: two market-beating stocks (both are up over 20% this year), solid upside potential, and recent million-dollar insider purchases. Here's a closer look at the names drawing insider confidence. Starz Entertainment (STRZ) The first stock we'll look at is new to the public trading markets, having gone public through a spinoff transaction that was completed early in May. Lionsgate Entertainment, a long-time stalwart of the film and music industry, split its motion picture and television studio operations and its premium subscription service business ops into two separate entities. The subscription business, Starz, is now trading as an independent company, and debuted on the NASDAQ index on May 7. Starz operates a TV streaming business, offering a variety of popular franchises and series. As a point of differentiation in a crowded industry, Starz bills itself as 'the leading premium entertainment destination for women and underrepresented audiences,' and its programming mix is designed to appeal to a discerning adult audience. Starz prides itself on its programming lineup, which it describes as including 'boundary-breaking' originals as well as blockbuster movies. After going public, Starz released its first set of financial results on May 29. The release covered FQ4 and the full fiscal year that ended this past March 31. For the fourth quarter, Starz reported total revenues of $330.6 million. At the bottom line, the company had a net quarterly operating loss of $136.3 million, and a positive OIBDA (Operating Income Before Depreciation and Amortization) of $93.3 million. Starz's stock has posted sound gains through its first month+ of trading, gaining 58%. But Mark Rachesky of the Board of Directors must sense more gains are on the way. The insider made a major purchase of STRZ stock on June 2, picking up 353,334 shares. This block is currently valued at $5.93 million. For Seaport analyst David Joyce, this newly public stock presents investors with a solid case for buying in. He writes of the shares, 'We believe STRZ has a clear path toward supporting its target demographic subscribers with original content that should support ARPU increases in time, EBITDA growth and margin expansion, FCF conversion, and debt paydown. Longer-term valuations for STRZ could be much higher (and closer to our adjusted blend of peer business mix-weighted multiples), up to $46 and conceivably even ~$56, once sentiment in the sector improves and differentiates among business models…' Joyce sets his initial rating on STRZ at a Buy, with a $30 price target that points toward a one-year gain of 78.5%. (To watch Joyce's track record, click here) Overall, Starz's new stock has earned a Moderate Buy consensus rating based on 3 reviews that include 2 to Buy and 1 to Hold. The shares are currently trading for $16.80 and their $21.33 average target price implies that the stock will gain 27% in the next 12 months. (See STRZ stock forecast) WNS Limited (WNS) The next stock we'll look at is WNS, the eponymous shares of WNS Limited. This firm is a $2.7 billion player in the global business transformation industry, providing the services and savvy in business process management that its clients need to adapt their operations to today's ever-changing environment. WNS is an Indian company on a global scene, with headquarters in Mumbai, London, and New York. The company employs more than 64,000 people in 13 countries around the world, working with more than 700 enterprise clients on 4 continents. This company's clientele is looking for a clear set of services, including digital technology and analytics, as well as AI-powered decision intelligence. WNS provides all of this, and more, assisting its client companies as they upgrade a wide range of business processes in finance and accounting, procurement, HR, research, and data management. The company works with customers in a wide range of industries, including high-tech, shipping and logistics, travel and leisure, utilities and energy, healthcare, insurance, and manufacturing. WNS has been in business since 1996, and has proven itself adaptable to the fast-moving changes of the business world. More recently, the company has added AI services to its line-up, offering its customers access to generative AI tools, in areas from medical summarization to generative AI response interfaces. Year-to-date, WNS shares are up 22%, while the company also beat expectations in its most recent quarterly readout. Those results covered fiscal 4Q25, the quarter ending this past March 31. At the top line, WNS had revenues of $336.3 million, flat year-over-year but some $12.67 million better than had been anticipated. The company's earnings, of $1.45 per share in non-GAAP measures, were 4 cents per share above the forecast. WNS also worked at paying down debt in the quarter; the company reported that it repaid $33 million after generating $53.4 million in cash from operations. At the end of the fiscal year, WNS had $267.4 million in cash and liquid assets on the balance sheet, compared to $243.5 million in debt. Turning to the insiders, we find that WNS's Executive Vice President Anil Chintapalli purchased two blocks of shares this past May, totaling 20,000. At current prices these shares are worth more than $1.19 million. This global company caught the eye of Baird analyst David Koning, who thinks that after a difficult period, the outlook looks upbeat for WNS, while it could also be an attractive takeover target. The 5-star analyst writes of the stock, 'After several one-off headwinds over the past couple years, WNS has returned to normalized sequential growth over the past two quarters. With the likelihood of ongoing normal sequential patterns, we think a return to organic constant-fx yoy growth in the high-single digits is likely by the September 2025 quarter. We think WNS remains an attractive target as (1) BPO (Business Process Outsourcing) has tended to grow faster in recent quarters, (2) BPO has tended to be more stable, (3) we could see cost synergies, (4) valuation is quite attractive relative to history.' At his own bottom line, Koning lays out an optimistic position, saying, 'We like the stock, as we view valuation as reasonable, and consider multiple ways to win…growth accelerates back to ~10%, investors like stable-growth BPO, or the company could sell.' These comments support Koning's Outperform (i.e., Buy) rating, and his $78 price target suggests that WNS will gain 31% over the next year. (To watch Koning's track record, click here) WNS has 6 recent reviews from Wall Street analysts, which break down 5 to 1 in favor of Buy over Hold for a Strong Buy consensus rating. The shares have a current selling price of $59.61 and the $72.20 average target price indicates room for a 21% upside in the next 12 months. (See WNS stock forecast) To find good ideas for stocks trading at attractive valuations, visit TipRanks' Best Stocks to Buy, a tool that unites all of TipRanks' equity insights. Disclaimer: The opinions expressed in this article are solely those of the featured analysts. The content is intended to be used for informational purposes only. It is very important to do your own analysis before making any investment. Disclaimer & DisclosureReport an Issue Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
16 minutes ago
- Yahoo
Investors in First Bank (NASDAQ:FRBA) have seen impressive returns of 126% over the past five years
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But when you pick a company that is really flourishing, you can make more than 100%. For example, the First Bank (NASDAQ:FRBA) share price has soared 108% in the last half decade. Most would be very happy with that. In the last week the share price is up 3.6%. With that in mind, it's worth seeing if the company's underlying fundamentals have been the driver of long term performance, or if there are some discrepancies. We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free. There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price. During five years of share price growth, First Bank achieved compound earnings per share (EPS) growth of 20% per year. This EPS growth is higher than the 16% average annual increase in the share price. So one could conclude that the broader market has become more cautious towards the stock. The reasonably low P/E ratio of 9.70 also suggests market apprehension. You can see below how EPS has changed over time (discover the exact values by clicking on the image). It's probably worth noting that the CEO is paid less than the median at similar sized companies. It's always worth keeping an eye on CEO pay, but a more important question is whether the company will grow earnings throughout the years. It might be well worthwhile taking a look at our free report on First Bank's earnings, revenue and cash flow. When looking at investment returns, it is important to consider the difference between total shareholder return (TSR) and share price return. The TSR incorporates the value of any spin-offs or discounted capital raisings, along with any dividends, based on the assumption that the dividends are reinvested. It's fair to say that the TSR gives a more complete picture for stocks that pay a dividend. We note that for First Bank the TSR over the last 5 years was 126%, which is better than the share price return mentioned above. This is largely a result of its dividend payments! It's good to see that First Bank has rewarded shareholders with a total shareholder return of 30% in the last twelve months. That's including the dividend. Since the one-year TSR is better than the five-year TSR (the latter coming in at 18% per year), it would seem that the stock's performance has improved in recent times. Someone with an optimistic perspective could view the recent improvement in TSR as indicating that the business itself is getting better with time. Before spending more time on First Bank it might be wise to click here to see if insiders have been buying or selling shares. For those who like to find winning investments this free list of undervalued companies with recent insider purchasing, could be just the ticket. Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on American exchanges. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
